INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY (EIN 872786093) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2021

Legal Domicile

Principal Officer

ERIC ESRAILIAN

Phone

6508047100

Tax Period

2022-07-01 to 2023-06-30

INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY, founded in 2021, is a community nonprofit in the Medical Research sector that reported $1.1M in total revenue in fiscal year 2022. The organization ran a surplus of $175K, a strong 16% operating margin.

Mission

MEDICAL SCIENCES RESEARCH INSTITUTE DEDICATED TO THE STUDY OF THE IMMUNE SYSTEM

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $1,108,746

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $1,108,746

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $861,501

Other Expenses $933,834

TOTAL EXPENSES $933,834

Year-over-Year Comparison

	2022	2021	Change
Revenue	$1,108,746	N/A	N/A
Expenses	$933,834	N/A	N/A
Net Income	$174,912	$0	N/A

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
GARY MICHELSON	BOARD CHAIR/DIRECTOR	1.00	Officer Director	$0	$0	$0
ERIC ESRAILIAN	PRESIDENT/DIRECTOR	1.00	Officer Director	$0	$0	$0
MEYER LUSKIN	TREASURER/SECRETARY/DIRECTOR	1.00	Officer Director	$0	$0	$0
ARIE BELLDEGRUN	DIRECTOR	1.00	Director	$0	$0	$0
MICHAEL MILKEN	DIRECTOR	1.00	Director	$0	$0	$0
SEAN PARKER	DIRECTOR	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	No data	No data	No data	No data
2023	$1,108,746	$933,834	$192,284	$174,912

INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY